Plus Therapeutics (PSTV) Earnings Date & Reports

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PSTV is expected to report earnings to fall 12.50% to -12 cents per share on August 16

Plus Therapeutics PSTV Stock Earnings Reports

Q2'23

Est.

$-0.12

Q1'23

Est.

$-0.14

Q4'22

Missed

by $0.62

Q3'22

Beat

by $0.01

Q2'22

Missed

by $0.02

The last earnings report on April 20 showed earnings per share of -14 cents, meeting the estimate of -14 cents. With 1.18M shares outstanding, the current market capitalization sits at 4.56M.

View a ticker or compare two or three

Compare

PSTV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PSTV
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

4200 Marathon Boulevard

Phone

+1 737 255-7194

Employees

Web

https://www.plustherapeutics.com